2019
DOI: 10.1016/j.jtho.2019.08.1728
|View full text |Cite
|
Sign up to set email alerts
|

P2.11-28 Late-Breaking Abstract - Clinical Potential of Sputum Hyaluronan Measurement in the Diagnosis and Prognosis of Patients with NSCLC

Abstract: Conclusion: We identified a distinct cluster of significant metabolic biomarkers associated with early-stage NSCLC. Tryptophan is the most significant one that associated with cancer metabolome. These would be potential biomarker profile for early-stage NSCLC detection.Larger cohort is needed to be validated.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles